News
Biogen/Eisai's Alzheimer's Drug Leqembi Gets 'No Go' From European Drug Regulator's Advisory Panel, Cites Serious Side Events
26 Jul 24
Biotech, Large Cap, News, Health Care, Top Stories, Movers, General
The Committee For Medicinal Products For Human Use Of The European Medicines Agency Has Adopted Negative Opinion On Approval Of Eisai/Biogen's Lecanemab As Treatment For Early Alzheimer's Disease, Eisai Said It Will Seek Re-Examination Of The Opinion
26 Jul 24
Biotech, Large Cap, News, Health Care, General
Bernie Sanders: 'Getting Sick In America Should Not Mean Going Bankrupt, Losing Your Home, Car, Or Life Savings'
15 Jul 24
News, Health Care, Politics, General
Eli Lilly's Alzheimer's Therapy's Broad Label Reflects Regulatory Confidence in Anti-Amyloid Antibodies: Analyst
3 Jul 24
Analyst Color, Biotech, Large Cap, News, Health Care, Reiteration, FDA, Top Stories, Analyst Ratings, Movers, Trading Ideas, General
Why Is Eli Lilly Stock Trading Higher Premarket Tuesday?
11 Jun 24
Equities, News, Movers, Media, General